About MINSHENG ROYAL FUND MANAGEMENT CO BIOTECHNOLOGY ETF CNY
Expense ratio
0.60%
Home page
Inception date
Aug 5, 2021
ISIN
CNE100004X99
Closely track the target index, pursue the minimization of tracking deviation and tracking err, and strive to achieve Long-term investment income consistent with the performance of the underlying index.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks96.09%
Health Technology85.65%
Commercial Services6.73%
Transportation1.09%
Producer Manufacturing0.86%
Health Services0.74%
Distribution Services0.61%
Retail Trade0.41%
Bonds, Cash & Other3.91%
Cash3.91%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history